High-throughout sequencing of triple negative breast cancer cells treated with Lespedeza bicolor root

The high-throughput sequencing technology was performed after the treatment of human triple negative breast cancer cells MDA-MB-231 and BT549 with Lespedeza bicolor root extracted by ourselves, to explore the expression of genes related to cell proliferation, adhesion, migration and invasion of human triple negative breast cancer cells MDA-MB-231 and BT549 after the treatment of Lespedeza bicolor root changes, and to find an interesting target gene. Human triple negative breast cancer cells MDA-MB-231 and BT549 were treated with Lespedeza bicolor root at the concentration of 5 µg/mL for 48 hours.